Downloads provided by UsageCounts
EP300 is one of the putative tumor-suppressor genes and is mutated/deleted, under expressed/overexpressed in several types of cancer. The role of EP300 and its interactions during cancer is crucial to explore its reprogramming events that lead to malignant phenotype and acquisition of drug resistance. In this context, all the experimentally valid EP300 interactors were collected from the primary protein-protein interaction (PPI) databases and followed by tracing their subcellular location using the UniProtKB database. Further, all the EP300 interactors were categorized based on their subcellular location and functionally annotated with the DAVID gene ontology tool. Subsequently, the interactome of EP300 with its interactors was constructed and identified TP53, CREBBP, JUN, HDAC1, CTNNB1, MYC, PCNA, HDAC2, FOS, and KAT2B as the top first neighbors of EP300. Together, the present analysis gives a comprehensive overview on EP300 interactors located in different subcellular locations
| selected citations These citations are derived from selected sources. This is an alternative to the "Influence" indicator, which also reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | 0 | |
| popularity This indicator reflects the "current" impact/attention (the "hype") of an article in the research community at large, based on the underlying citation network. | Average | |
| influence This indicator reflects the overall/total impact of an article in the research community at large, based on the underlying citation network (diachronically). | Average | |
| impulse This indicator reflects the initial momentum of an article directly after its publication, based on the underlying citation network. | Average |
| views | 9 | |
| downloads | 11 |

Views provided by UsageCounts
Downloads provided by UsageCounts